Impact of Pre-Treatment NLR and Other Hematologic Biomarkers on the Outcomes of Early-Stage Non-Small-Cell Lung Cancer Treated with Stereotactic Body Radiation Therapy

Introduction: We evaluated the association of pre-treatment immunologic biomarkers on the outcomes of early-stage non-small-cell lung cancer (NSCLC) patients treated with stereotactic body radiation therapy (SBRT). Materials and methods: In this retrospective study, all newly diagnosed early-stage N...

Descripción completa

Detalles Bibliográficos
Autores principales: AduQuaye, Marina, Dube, Sheen, Bashir, Bashir, Chowdhury, Amitava, Ahmed, Naseer, Leylek, Ahmet, Kim, Julian, Lambert, Pascal, Bucher, Oliver, Hunter, William, Sivananthan, Gokulan, Koul, Rashmi, Rathod, Shrinivas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8774597/
https://www.ncbi.nlm.nih.gov/pubmed/35049693
http://dx.doi.org/10.3390/curroncol29010019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8774597/
https://www.ncbi.nlm.nih.gov/pubmed/35049693
http://dx.doi.org/10.3390/curroncol29010019

Ejemplares similares